Impact factor jama oncol
Witryna11 lis 2024 · This cohort study compares the toxic effects and oncologic outcomes associated with intensity-modulated radiation therapy (IMRT) vs intensity-modulated proton t ... JAMA Oncol. 2024;8(3):364-372. doi: ... IMPT was the only factor associated with significantly lower likelihood of developing grade 3 or greater acute … Witryna1 lip 2024 · The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years. …
Impact factor jama oncol
Did you know?
Witryna2374-2437 (print) 2374-2445 (web) Links. Journal homepage. Online access. Online archive. JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was … Witryna1 lip 2024 · The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years. Total Citations in 2024 and 2024 = 500. Total Number of Publications in 2024 and 2024 = 100. Impact Factor of the Journal in 2024 = 500/100 = 5.
WitrynaThe Lancet Oncology is an internationally trusted source of clinical, public health, and global health knowledge. With an Impact Factor of 54·433, we are the world-leading clinical oncology research journal globally (2024 Journal Citation Reports ®, Clarivate 2024). We recognise that the Journal Impact Factor is just one measure of a journal ... Witryna23 mar 2024 · 子宫腺肌症介绍，子宫腺肌症治疗方式，子宫腺肌症日常注意事项，壹大家好，今天和大家分享一篇发表在医学杂志JAMA上关于子宫腺肌症的临床更新。这篇临床更新总结了子宫腺肌症的诊断和管理，并提供了建议的治疗方法。概述子宫腺肌症是一种以子宫内膜腺体和基质出现在子宫肌层存
WitrynaThe budget impact of introducing avelumab was estimated to be approximately cost-neutral with a marginal increase of $719,324 (0.25% change in budget) in incremental total costs over the three-year time period ( Figure 2, Table 6 ). The incremental PMPM cost was approximately zero ($0.00) over 3 years. WitrynaIt measures the number of times an average paper in a particular journal has been referred to elsewhere in scientific literature. The Impact Factor of journal J in the calendar year X is the number of citations received by J in X to any item published in J in (X-1) or (X-2), divided by the number of source items published in J in (X-1) or (X-2).
Witryna1 mar 2024 · JAMA Oncol. 2024 Mar 1;7(3):386 ... Although treatment with first-generation epidermal growth factor receptor (EGFR) ... (80 mg, every day) plus intravenous bevacizumab (15 mg/kg, every 3 weeks) until progression or unacceptable toxic effects. The control arm received osimertinib monotherapy.
WitrynaThe impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of … bits microinformáticaWitryna1 sie 2024 · JAMA Oncol. 2024 Aug 1;6(8):1210-1217. doi: ... These findings suggest that the total volume of sedentary behavior is a potential cancer mortality risk factor and support the public health message that adults should sit less and move more to promote longevity. MeSH terms data recovery athens gaWitryna1 gru 2024 · Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial ... JAMA Oncol. 2024 Dec 1;4(12):1729-1735 ... Treatment was outpatient with reversible neuropathic pain and without unexpected toxic effects. No … data recovery bedford countyWitrynaJAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and … datarecovery belgieWitrynaThis study aims to show that split-course therapy may achieve good local control tumor response rates at 6 months for those patients who are unfit to tolerate continuous therapy, and may be better tolerated, with decreased side effects. 103 Appropriate patient selection is critical, given that split-course therapy carries the potential risk of ... data recovery app for androidWitryna1 paź 2024 · JAMA Oncol. 2024 Oct 1;5(10):1489-1496. doi: 10.1001/jamaoncol.2024.0620. Authors ... Observations: A higher proportion of premenopausal BCs occur in Asia, although this factor is possibly an age-cohort effect. Although the relative frequencies of different immunohistochemical subtypes of BC … data recovery bahrainWitryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ... JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. bits mesra ranchi nirf ranking